Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
JAMA Network Open|July 25, 2025
Adherence to Quality-of-Care Indicators and Mortality Outcomes in Patients With MRSA Bacteremia: A Post Hoc Analysis of the CAMERA2 Randomized Clinical TrialI Russel Lee, Yanan Zhu, Neela J Rai, et al.
BMC Medicine|June 9, 2020
Responding to COVID-19: how an academic infectious diseases division mobilized in SingaporeSophia Archuleta, Gail Cross, Jyoti Somani, et al.
The Lancet. Infectious Diseases|October 9, 2025
Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trialDavid L Paterson, Helmi Sulaiman, Po-Yu Liu, et al.
Open Forum Infectious Diseases|July 27, 2023
Longer-term Mortality and Kidney Outcomes of Participants in the Combination Antibiotics for Methicillin-Resistant Staphylococcus aureus (CAMERA2) Trial: A Post Hoc AnalysisAmy Legg, Matthew A Roberts, Jane Davies, et al.
The European Respiratory Journal|June 27, 2020
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC)Catherine Wei Min Ong, Giovanni Battista Migliori, Mario Raviglione, et al.
JAMA|February 12, 2020
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical TrialSteven Y C Tong, David C Lye, Dafna Yahav, et al.
The New England Journal of Medicine|June 17, 2026
Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia, Todd C Lee, Lauren A Barina, et al.
Pageof 9